GSK-239512 Uses, Dosage, Side Effects and more
GSK-239512 is under investigation in clinical trial NCT00474513 (An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.).
| Trade Name | GSK-239512 |
| Generic | GSK-239512 |
| Type | |
| Formula | C23H27N3O2 |
| Weight | Average: 377.488 Monoisotopic: 377.210327121 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
